Latest press and news

Oct 1

Press Releases Regulatory

Last patient successfully enrolled in the world’s first interventional trial with 3D microtumors as guide for choice of cancer treatment.

Sep 14

Press Releases

2cureX launches world’s first CE-marked microtumor test service

Aug 27

Press Releases Regulatory

2cureX AB (“2cureX”) hereby publishes the interim report for the first half of 2020

Aug 4

Press Releases

First day for trading in TO1 series warrants

Jul 13

Press Releases Regulatory

Record date for allotment of warrants of series TO1 is set to July 17, 2020

Jul 6

Press Releases Regulatory

2cureX completes a heavily oversubscribed directed issue of approximately SEK 40 million

Jul 6

Press Releases Regulatory

2cureX AB intends to carry out a directed issue of units

Jul 3

Press Releases

2cureX AB expands its Board of Directors with Michael Lutz and Nils Brünner